Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer

Pancreatic cancer (PC) is a fatal disease that has a poor 5-year survival rate. The poor prognosis can be attributed to both troublesome detections at the initial stage, which makes the majority of the treatment options largely unsuccessful and leads to extensive metastasis, as well as to its distin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhe, Parveen, Neha, Rehman, Urushi, Aziz, Aisha, Sheikh, Afsana, Abourehab, Mohammed A. S., Guo, Wei, Huang, Junhao, Wang, Zhenning, Kesharwani, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835391/
https://www.ncbi.nlm.nih.gov/pubmed/36635659
http://dx.doi.org/10.1186/s12943-022-01696-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835391/
https://www.ncbi.nlm.nih.gov/pubmed/36635659
http://dx.doi.org/10.1186/s12943-022-01696-5

Ejemplares similares